6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Press Release Apr 29 2026
2m ago	Colgate, in partnership with Hong Kong Dental Association, launches TOTAL Periodontal Health Lab
28m ago	Navios Maritime Partners L.P. Announces First Day of Trading of Bonds at Euronext Oslo Børs
29m ago	Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
29m ago	Fiverr Announces First Quarter 2026 Results

About

Everest Medicines Ltd (HK:1952) — investor relations, events, news, and company updates on 6ix.

Latest News

Everest Medicines Signs Share Purchase Agreement with Hasten Biopharmaceuticals (Asia) Limited

Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China

Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited

Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026 and Hold Online Earnings Call

Everest Medicines' Licensing Partner NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study

Financials

Revenue

HK$1.71 B

Market Cap

HK$14.41 B

EPS

-0.77

Community Chat

Ask AI